Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.19.3
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2017   24,766,892        
Beginning balance at Dec. 31, 2017 $ 33,695,145 $ 24,767 $ 56,176,330 $ (165,317) $ (22,796,246) $ 455,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Reclassification of Accumulated Other Comprehensive Loss       165,317 (165,317)  
Exercise of stock options (shares)   52,754        
Exercise of stock options 63,304 $ 52 63,252      
Stock issuance costs (1,807)   (1,807)      
Stock based compensation expense 133,808   133,808      
Distributions to Noncontrolling interests (68,950)         (68,950)
Net income (loss) (1,336,628)       (1,336,628)  
Net loss (58,946)         (58,946)
Net income (loss) (1,277,682)          
Ending balance (shares) at Sep. 30, 2018   24,819,646        
Ending balance at Sep. 30, 2018 32,543,818 $ 24,819 56,371,583 0 (24,298,191) 445,607
Beginning balance (shares) at Jun. 30, 2018   24,819,646        
Beginning balance at Jun. 30, 2018 33,099,703 $ 24,819 56,317,160   (23,695,154) 452,878
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock issuance costs (907)   (907)      
Stock based compensation expense 55,330   55,330      
Distributions to Noncontrolling interests (34,650)         (34,650)
Net income (loss) (603,037)       (603,037)  
Net loss (27,379)         (27,379)
Net income (loss) (575,658)          
Ending balance (shares) at Sep. 30, 2018   24,819,646        
Ending balance at Sep. 30, 2018 32,543,818 $ 24,819 56,371,583 $ 0 (24,298,191) 445,607
Beginning balance (shares) at Dec. 31, 2018   24,824,746        
Beginning balance at Dec. 31, 2018 28,037,774 $ 24,825 56,427,928   (28,670,095) 255,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)   18,515        
Exercise of stock options 26,417 $ 18 26,399      
Stock issuance costs (1,011)   (1,011)      
Stock based compensation expense 120,604   120,604      
Distributions to Noncontrolling interests (48,126)         (48,126)
Net income (loss) (4,223,455)       (4,223,455)  
Net loss 94,551         94,551
Net income (loss) (4,318,006)          
Ending balance (shares) at Sep. 30, 2019   24,843,261        
Ending balance at Sep. 30, 2019 23,817,652 $ 24,843 56,573,920   (32,893,550) 112,439
Beginning balance (shares) at Jun. 30, 2019   24,840,806        
Beginning balance at Jun. 30, 2019 24,354,421 $ 24,841 56,525,590   (32,307,301) 111,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)   2,455        
Exercise of stock options 5,661 $ 2 5,659      
Stock based compensation expense 42,671   42,671      
Distributions to Noncontrolling interests (20,713)         (20,713)
Net income (loss) (586,249)       (586,249)  
Net loss (21,861)         (21,861)
Net income (loss) (564,388)          
Ending balance (shares) at Sep. 30, 2019   24,843,261        
Ending balance at Sep. 30, 2019 $ 23,817,652 $ 24,843 $ 56,573,920   $ (32,893,550) $ 112,439